Trials / Unknown
UnknownNCT04699994
Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel
Multicenter Phase II Trial to Evaluate the Safety and Efficacy of FLOT Therapy for Resectable Esophageal Squamous Cell Carcinoma (Preoperative FLOT PII)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Keio University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The current multicenter prospective phase II study aims to evaluate the safety and efficacy of preoperative FLOT therapy for esophageal squamous cell carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FLOT therapy | Preoperative FLOT therapy |
Timeline
- Start date
- 2020-06-25
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
- First posted
- 2021-01-07
- Last updated
- 2022-08-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04699994. Inclusion in this directory is not an endorsement.